Prokineticin 2 (PK2) Rescues Cardiomyocytes from High Glucose/High Palmitic Acid-Induced Damage by Regulating the AKT/GSK3β Pathway In Vitro

Figure 1

PK2 decreased intracellular ROS production in high glucose/high palmitic acid-treated cardiomyocytes. (a) Representative images of DHE staining, , , independent groups. (b) Quantification of DCFH-DA staining, independent groups. (c) SOD level, independent groups. (d) MDA level, independent groups. NG: normal glucose; HG-PA: high glucose/high palmitic acid; NG-PK2: normal glucose plus PK2; HG-PA-PK2: high glucose/high palmitic acid plus PK2. versus the NG group; ^# versus the HG-PA group.

(a)

(b)

(c)

(d)